Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies
Clinical trial NCT03624686 · UNKNOWN
Trial details
- NCT number
- NCT03624686
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-09
- Primary completion
- 2020-12-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.